Advertisement

Current Practical Guidelines for the Most Common Nuclear Medicine Procedures

  • Irene Marini
  • Onelio Geatti
  • H. William Strauss
Chapter

Learning Objectives

  • This chapter presents a focused overview of procedure guidelines published by the European Association of Nuclear Medicine (EANM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

  • This edited presentation of the guidelines describes the clinical indications, patient preparation, preferred radiopharmaceuticals, data processing and criteria for interpretation of common clinical procedures.

Lymphoscintigraphy for Radio-Guided Sentinel Lymph Node Biopsy in Patients with Breast Cancer

The sentinel lymph node (SLN) is the first lymph node that drains lymph and possibly metastatic tumour cells from the site of a tumour. Preoperative lymphoscintigraphy (LS) allows localisation of the sentinel lymph node(s) to be harvested during radioguided sentinel lymph node biopsy.

Indications

The procedure should be performed in patients when surgical resection of the primary tumour and axillary lymph node clearance is planned for patients who have biopsy-proven breast...

Keywords

Sentinel lymph node in breast cancer Sentinel lymph node in cutaneous melanoma [18F]FDG PET/CT in oncology Perfusion brain SPECT Brain SPECT with 123I-labelled dopamine transporter ligands SPECT and PET with dopamine D2 receptor ligands Brain PET with [18F]FDG Imaging of brain tumours with amino acid tracers Myocardial perfusion scintigraphy Ventilation/perfusion scintigraphy Bone scintigraphy with 99mTc-labelled bone-seeking agents Scintigraphy with 99mTc-HMPAO-labelled autologous leucocytes Thyroid scintigraphy Radiometabolic therapy with 131I-iodide for hyperthyroidism Radiometabolic therapy with 131I-iodide for differentiated thyroid cancer PET/CT with 68Ga-PSMA-ligands Parathyroid scintigraphy PET/CT with 68Ga-DOTA-Somatostatin analogues Therapy with 131I-MIBG Dynamic renal scintigraphy 

Further Reading

  1. Bajc M, Neilly JB, Miniati M, Schuemichen C, Meignan M, Jonson B, et al. EANM guidelines for ventilation/perfusion scintigraphy: Part 1. Pulmonary imaging with ventilation/perfusion single photon emission tomography. Eur J Nucl Med Mol Imaging. 2009;36:1356–70. http://eanm.org/publications/guidelines/gl_pulm_embolism_part1.pdf CrossRefGoogle Scholar
  2. Bajc M, Neilly JB, Miniati M, Schuemichen C, Meignan M, Jonson B, et al. EANM guidelines for ventilation/perfusion scintigraphy: Part 2. Algorithms and clinical considerations for diagnosis of pulmonary emboli with V/P(SPECT) and MDCT. Eur J Nucl Med Mol Imaging. 2009;36:1528–38. http://eanm.org/publications/guidelines/gl_pulm_embolism_part2.pdf CrossRefGoogle Scholar
  3. Balon HR, Silberstein EB, Donald A Meier DA, Charkes ND, Sarkar SD, et al. Society of Nuclear Medicine Procedure Guideline for Thyroid Scintigraphy. V3.0. http://snmmi.files.cms-plus.com/docs/Thyroid_Scintigraphy_V3.pdf
  4. Blaufox MD, De Palma D, Taylor A, Szabo Z, Prigent A, Samal M, et al. The SNMMI and EANM practice guideline for renal scintigraphy in adults. Eur J Nucl Med Mol Imaging. 2018;45:2218–28. http://snmmi.files.cms-plus.com/FileDownloads/ProcedureStandards/Renal%20Scintigraphy_Blaufox_0318.pdf CrossRefGoogle Scholar
  5. Bluemel C, Herrmann K, Giammarile F, Nieweg OE, Dubreuil J, Testori A, et al. EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma. Eur J Nucl Med Mol Imaging. 2015;42:1750–66. http://snmmi.files.cms-plus.com/ACNM/Documents/2015_EANM_PracticeGL_Lymphoscintigraphy.pdf CrossRefGoogle Scholar
  6. Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54. http://www.eanm.org/publications/guidelines/2015_GL_PET_CT_TumorImaging_V2.pdf CrossRefGoogle Scholar
  7. Buscombe J, Paganelli G, Burak ZE, Waddington W, Maublant J, Prats E, et al. Sentinel node in breast cancer procedural guidelines. Eur J Nucl Med Mol Imaging. 2007;34:2154–9. http://www.eanm.org/publications/guidelines/gl_onco_sent_node.pdf CrossRefGoogle Scholar
  8. Chakera AH, Hesse B, Burak Z, Ballinger JR, Britten A, Caracò C, et al. EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging. 2009;36:1713–42. http://www.eanm.org/publications/guidelines/gl_onco_eanm_eortc.pdf CrossRefGoogle Scholar
  9. Crawford ES, Guarasci DT, Larson SA. A survey of thyroid gland scintigraphy. J Nucl Med Technol. 2009;37:173–8.CrossRefGoogle Scholar
  10. Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu OL, et al. EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37:443–50. http://www.eanm.org/publications/guidelines/gl_neuro_spet_trans.pdf CrossRefGoogle Scholar
  11. De Man KE, Troch ME, Dobbeleir AA, Duong HP, Goethals IM. Comparison of the EANM and SNM guidelines on diuretic renography in children. Nucl Med Commun. 2015;36:486–8.PubMedGoogle Scholar
  12. de Vries EF, Roca M, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with 99mTc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010;37:842–8. Erratum in: Eur J Nucl Med Mol Imaging. 2010;37:1235. http://www.eanm.org/publications/guidelines/2_EJNMMI_InfInf_GL_WBCLabelling_99mTc_04_2010.pdf CrossRefGoogle Scholar
  13. Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47:885–95. Erratum in: J Nucl Med. 2006;47:903. http://snmmi.files.cms-plus.com/docs/jnm30551_online.pdf Google Scholar
  14. Donohoe KJ, Brown ML, Collier BD, Carretta RF, Henkin RE, O’Mara RE et al. Society of Nuclear Medicine procedure guideline for bone scintigraphy version 3.0. 2003. http://snmmi.files.cms-plus.com/docs/pg_ch34_0403.pdf
  15. Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, et al. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med. 2013;54:1485–507. http://snmmi.files.cms-plus.com/docs/ASNC_SCCT_SNMMI%20Guideline%20for%20Cardiac%20SPECT-CT%20and%20PET-CT.pdf CrossRefGoogle Scholar
  16. Fendler WP, Eiber M, Beheshti M, Bomanji J, Ceci F, Cho S, et al. 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2017;44:1014–24. http://snmmi.files.cms-plus.com/Quality/68Ga-PSMA%20PET%20CT%20Joint%20EANM%20and%20SNMMI%20procedure%20guideline%20for%20prostate%20imaging.pdfs CrossRefGoogle Scholar
  17. Giammarile F, Alazraki N, Aarsvold JN, Audisio RA, Glass E, Grant SF, et al. The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer. Eur J Nucl Med Mol Imaging. 2013;40:1932–47. http://snmmi.files.cms-plus.com/docs/Final%20Breast%20Sentinel%20Node%20Guideline.pdf CrossRefGoogle Scholar
  18. Giammarile F, Chiti A, Lassmann M, Brans B, Flux G, EANM. EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy. Eur J Nucl Med Mol Imaging. 2008;35:1039–47. http://eanm.org/publications/guidelines/gl_radio_ther_benzyl.pdf CrossRefGoogle Scholar
  19. Gordon I, Piepsz A, Sixt R. Guidelines for standard and diuretic renogram in children. Eur J Nucl Med Mol Imaging. 2011;38:1175–88. http://eanm.org/publications/guidelines/gl_paed_renogram_2011.pdf CrossRefGoogle Scholar
  20. Greenspan BS, Dillehay G, Intenzo C, Lavely WC, O'Doherty M, Palestro CJ, et al. SNM practice guideline for parathyroid scintigraphy 4.0. J Nucl Med Technol. 2012;40:111–8. http://snmmi.files.cms-plus.com/docs/Parathyroid_Scintigraphy_V4_0_FINAL.pdf CrossRefGoogle Scholar
  21. Hindié E, Ugur O, Fuster D, O'Doherty M, Grassetto G, Ureña P, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009;36:1201–16. http://eanm.org/publications/guidelines/gl_parathyroid_2009.pdf CrossRefGoogle Scholar
  22. Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, et al. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med. 2013;54:647–58. http://snmmi.files.cms-plus.com/docs/Inflammation%20and%20infection.pdf CrossRefGoogle Scholar
  23. Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, Någren K, et al. EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2. Eur J Nucl Med Mol Imaging. 2009;36:2093–102. www.eanm.org/publications/guidelines/gl_neuro_spet_radio.pdf CrossRefGoogle Scholar
  24. Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oyen WJ, et al. Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2008;35:1941–59. http://eanm.org/publications/guidelines/gl_radio_ther_259_883.pdf CrossRefGoogle Scholar
  25. Palestro CJ, Brown ML, Forstrom LA, Greenspan BS, McAfee JG, Royal HD, et al. Society of Nuclear Medicine procedure guideline for 99mTc-exametazime (HMPAO)-labeled leukocyte scintigraphy for suspected infection/inflammation. http://snmmi.files.cms-plus.com/docs/HMPAO_v3.pdf
  26. Parker JA, Coleman RE, Grady E, Royal HD, Siegel BA, Stabin MG, et al. SNM practice guideline for lung scintigraphy 4.0. J Nucl Med Technol. 2012;40:57–65. Erratum in: J Nucl Med Technol. 2016;44:271. http://snmmi.files.cms-plus.com/ACNM/Documents/Lung_Scintigraphy_V4_Final.pdf CrossRefGoogle Scholar
  27. Silberstein EB, Alavi A, Balon HR, Becker D, Charkes ND, Clarke SEM, et al. Society of Nuclear Medicine procedure guideline for scintigraphy for differentiated papillary and follicular thyroid cancer. http://snmmi.files.cms-plus.com/docs/Scintigraphy%20for%20Differentiated%20Thyroid%20Cancer%20V3%200%20(9-25-06).pdf
  28. Silberstein EB, Alavi A, Balon HR, Clarke SE, Divgi C, Gelfand MJ, et al. The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0. J Nucl Med. 2012;53:1633–51. http://snmmi.files.cms-plus.com/docs/I-131_V3.0_JNM_pub_version.pdf CrossRefGoogle Scholar
  29. Stauss J, Hahn K, Mann M, De Palma D. Guidelines for paediatric bone scanning with 99mTc-labelled radiopharmaceuticals and 18F-fluoride. Eur J Nucl Med Mol Imaging. 2010;37:1621–8. http://eanm.org/publications/guidelines/EJNMMI_Bone_Scintigraphy_in_Children.pdf CrossRefGoogle Scholar
  30. Stokkel MP, Handkiewicz Junak D, Lassmann M, Dietlein M, Luster M. EANM procedure guidelines for therapy of benign thyroid disease. Eur J Nucl Med Mol Imaging. 2010;37:2218–28. http://eanm.org/publications/guidelines/gl_EJNMMI_therapy_of_benign_thyroid_disease.pdf CrossRefGoogle Scholar
  31. Taylor AT, Brandon DC, de Palma D, Blaufox MD, Durand E, Erbas B, et al. SNMMI procedure standard/EANM practice guideline for diuretic renal scintigraphy in adults with suspected upper urinary tract obstruction 1.0. Semin Nucl Med. 2018;48:377–90. https://www.eanm.org/content-eanm/uploads/2018/06/2018_SNMMI-EANM-diuretic-guideline.pdf CrossRefGoogle Scholar
  32. Taïeb D, Timmers HJ, Hindié E, Guillet BA, Neumann HP, Walz MK, et al. EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2012;39:1977–95. http://www.eanm.org/publications/guidelines/2012_published_OC_GL_Radionuclide_Imaging_of_Phaeochromocytoma_and_Paraganglioma.pdf CrossRefGoogle Scholar
  33. Van den Wyngaert T, Strobel K, Kampen WU, Kuwert T, van der Bruggen W, Mohan HK, et al. The EANM practice guidelines for bone scintigraphy. Eur J Nucl Med Mol Imaging. 2016;43:1723–38. http://www.eanm.org/publications/guidelines/EANM_Bone_Scintigraphy_GL_2016.pdf CrossRefGoogle Scholar
  34. Van Laere K, Varrone A, Booij J, Vander Borght T, Nobili F, Kapucu OL, et al. EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37:434–42. http://www.eanm.org/publications/guidelines/gl_neuro_spet_d2.pdf CrossRefGoogle Scholar
  35. Vander Borght T, Asenbaum S, Bartenstein P, Halldin C, Kapucu O, Van Laere K, et al. EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues. Eur J Nucl Med Mol Imaging. 2006;33:1374–80. http://www.eanm.org/publications/guidelines/gl_neuro_brain_tumor_060327.pdf CrossRefGoogle Scholar
  36. Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Någren K, et al. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging. 2009;36:2103–10. http://www.eanm.org/publications/guidelines/gl_neuro_img_fdg.pdf CrossRefGoogle Scholar
  37. Verberne HJ, Acampa W, Anagnostopoulos C, Ballinger J, Bengel F, De Bondt P, et al. EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl Med Mol Imaging. 2015;42:1929–40. http://eanm.org/publications/guidelines/2015_07_EANM_FINAL_myocardial_perfusion_guideline.pdf CrossRefGoogle Scholar
  38. Virgolini I, Ambrosini V, Bomanji JB, Baum RP, Fanti S, Gabriel M, et al. Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE. Eur J Nucl Med Mol Imaging. 2010;37:2004–10. http://www.eanm.org/publications/guidelines/gl_Ga68DOTA.pdf CrossRefGoogle Scholar
  39. Waxman AD, Herholz K, Lewis DH, Herscovitch P, Minoshima S, Masanori I, et al. Society of Nuclear Medicine procedure guideline for FDG PET brain imaging version 1.0. 2009. http://snmmi.files.cms-plus.com/docs/Society%20of%20Nuclear%20Medicine%20Procedure%20Guideline%20for%20FDG%20PET%20Brain%20Imaging.pdf

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Irene Marini
    • 1
  • Onelio Geatti
    • 2
  • H. William Strauss
    • 3
  1. 1.Nuclear Medicine InstituteUniversità Cattolica del Sacro Cuore and Nuclear Medicine Center, Fondazione Policlinico Universitario A. Gemelli IRCCSRomeItaly
  2. 2.Nuclear Medicine CenterUniversity Hospital of UdineUdineItaly
  3. 3.Molecular Imaging and Therapy ServiceMemorial Sloan Kettering Cancer CenterNew YorkUSA

Personalised recommendations